v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]        
Net sales $ 338,357 $ 390,351 $ 1,090,360 $ 1,196,432
Cost of sales 267,965 305,701 877,451 936,720
Gross profit 70,392 84,650 212,909 259,712
Selling, general and administrative expenses 59,078 62,934 185,493 204,417
Goodwill impairment 31,018 110,251 150,926 201,518
Long-lived asset and intangibles impairment 15,047 24,012 26,964 42,029
Productivity and transformation costs 4,066 7,289 17,519 16,497
Amortization of acquired intangible assets 3,314 1,243 5,725 5,176
Proceeds from insurance claim 0 0 (25,900) 0
Operating loss (42,131) (121,079) (147,818) (209,925)
Interest and other financing expense, net 13,914 11,866 45,075 38,412
Other expense, net 49,518 1,182 47,865 2,434
Loss before income taxes and equity in net loss of equity-method investees (105,563) (134,127) (240,758) (250,771)
Provision (benefit) for income taxes 759 (505) 1,889 5,746
Equity in net loss of equity-method investees 21 966 327 1,709
Net loss $ (106,343) $ (134,588) $ (242,974) $ (258,226)
Net loss per common share:        
Basic $ (1.17) $ (1.49) $ (2.68) $ (2.87)
Diluted $ (1.17) $ (1.49) $ (2.68) $ (2.87)
Shares used in the calculation of net loss per common share:        
Basic 90,993 90,247 90,650 90,080
Diluted 90,993 90,247 90,650 90,080